The University of Chicago Header Logo

Connection

Nina Paleologos to Brain Neoplasms

Back to Details
This is a "connection" page, showing publications Nina Paleologos has written about Brain Neoplasms.
Nina Paleologos
Connection Strength
2.324
Brain Neoplasms
  1. Chemotherapy for low-grade gliomas. Expert Rev Neurother. 2005 Nov; 5(6 Suppl):S21-4.
    View in: PubMed
    Score: 0.179
  2. A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. Neuro Oncol. 2020 10 14; 22(10):1505-1515.
    View in: PubMed
    Score: 0.126
  3. Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma. Neurology. 1999 Sep 22; 53(5):1141-3.
    View in: PubMed
    Score: 0.117
  4. Treatment of oligodendroglioma: an update. Neuro Oncol. 1999 Jan; 1(1):61-8.
    View in: PubMed
    Score: 0.112
  5. Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma. Neuro Oncol. 2017 Oct 01; 19(10):1380-1390.
    View in: PubMed
    Score: 0.102
  6. A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. J Neurooncol. 2016 Jan; 126(1):185-192.
    View in: PubMed
    Score: 0.091
  7. A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study. Neuro Oncol. 2015 Jun; 17(6):854-61.
    View in: PubMed
    Score: 0.085
  8. External beam radiotherapy: hard facts and painful realities. J Neurooncol. 1995; 24(1):93-5.
    View in: PubMed
    Score: 0.085
  9. Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors. Neuro Oncol. 2014 Nov; 16(11):1541-6.
    View in: PubMed
    Score: 0.082
  10. Intravenous thrombolysis for ischemic stroke in recurrent oligodendroglioma: a case report. J Stroke Cerebrovasc Dis. 2014 May-Jun; 23(5):1235-8.
    View in: PubMed
    Score: 0.078
  11. Initial treatment patterns over time for anaplastic oligodendroglial tumors. Neuro Oncol. 2012 Jun; 14(6):761-7.
    View in: PubMed
    Score: 0.071
  12. International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol. 2011 Jun; 13(6):649-59.
    View in: PubMed
    Score: 0.066
  13. Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Jun; 13(6):660-8.
    View in: PubMed
    Score: 0.066
  14. Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. Oncologist. 2010; 15(12):1329-34.
    View in: PubMed
    Score: 0.064
  15. Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Jan; 13(1):143-51.
    View in: PubMed
    Score: 0.064
  16. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010 Jan; 96(1):45-68.
    View in: PubMed
    Score: 0.059
  17. The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010 Jan; 96(1):71-83.
    View in: PubMed
    Score: 0.059
  18. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010 Jan; 96(1):33-43.
    View in: PubMed
    Score: 0.059
  19. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010 Jan; 96(1):17-32.
    View in: PubMed
    Score: 0.059
  20. The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics. J Neurooncol. 2010 Jan; 96(1):115-42.
    View in: PubMed
    Score: 0.059
  21. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010 Jan; 96(1):103-14.
    View in: PubMed
    Score: 0.059
  22. The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010 Jan; 96(1):97-102.
    View in: PubMed
    Score: 0.059
  23. The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010 Jan; 96(1):85-96.
    View in: PubMed
    Score: 0.059
  24. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009 Oct 01; 27(28):4733-40.
    View in: PubMed
    Score: 0.058
  25. Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma. J Neurooncol. 2009 Mar; 92(1):57-63.
    View in: PubMed
    Score: 0.055
  26. A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis. J Neurooncol. 2008 Sep; 89(2):187-93.
    View in: PubMed
    Score: 0.053
  27. Survey of treatment recommendations for anaplastic oligodendroglioma. Neuro Oncol. 2007 Jul; 9(3):314-8.
    View in: PubMed
    Score: 0.050
  28. High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up. Neuro Oncol. 2006 Apr; 8(2):183-8.
    View in: PubMed
    Score: 0.046
  29. High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma. J Neurooncol. 2003 Nov; 65(2):127-34.
    View in: PubMed
    Score: 0.039
  30. Myeloablative chemotherapy for recurrent aggressive oligodendroglioma. Neuro Oncol. 2000 04; 2(2):114-9.
    View in: PubMed
    Score: 0.030
  31. Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. J Clin Oncol. 1998 Jun; 16(6):2202-12.
    View in: PubMed
    Score: 0.027
  32. Salvage chemotherapy for oligodendroglioma. J Neurosurg. 1996 Oct; 85(4):597-601.
    View in: PubMed
    Score: 0.024
  33. Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results. Clin Cancer Res. 1996 Jun; 2(6):963-72.
    View in: PubMed
    Score: 0.023
  34. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium. Int J Radiat Oncol Biol Phys. 1996 Mar 01; 34(4):793-802.
    View in: PubMed
    Score: 0.023
  35. Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol. 2012 07; 108(3):491-8.
    View in: PubMed
    Score: 0.017
  36. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol. 1990 Dec; 28(6):818-22.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.